Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism, excessive hair growth in women, is often caused by polycystic ovarian syndrome and is treated by targeting the cause, lifestyle changes, and medication.

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Women with PCOS have more severe liver disease.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Skin problems like acne, excessive hair growth, and oily skin are common in women with PCOS and can help with early diagnosis.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Ovarian drilling surgery is not clearly better than medical treatments for PCOS symptoms.

PCOS affects fertility and is linked to obesity and menstrual irregularities; lifestyle changes are recommended for treatment.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

The genetic variant studied does not affect PCOS symptoms in Kashmiri women.

Skin problems like acne and excess hair in PCOS are common and linked to being overweight.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.